Alejandra Aroca-Crevillén

Alejandra Aroca-Crevillén

Auto-generated profile, based on publicly available information

Alejandra Aroca-Crevillén

Cardiovascular Risk Factors and Brain Function Programme (S.V.-R., A.G.-C., F.J.D.C.-M., C.N.-V., A.R.-S., E.M.-C., C.P.-P., A.R.-P., A.A.-C., I.B., M.I.C., M.A.M.), Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cell
Verified
Journal Article
Closed access
IBIván Ballesteros
Iván Ballesteros
ARAndrea Rubio-Ponce
Andrea Rubio-Ponce
MGMarco Genua
Marco Genua
ELEleonora Lusito
Eleonora Lusito
IKImmanuel Kwok
Immanuel Kwok
AHAndrés Hidalgo
Andrés Hidalgo

5 January 2022 in Nature
Verified
Journal Article
Closed access
PDF file
GCGeorgiana Crainiciuc
Georgiana Crainiciuc
MPMiguel Palomino-Segura
Miguel Palomino-Segura
MMMiguel Molina-Moreno
Miguel Molina-Moreno
JSJon Sicilia
Jon Sicilia
DADavid G. Aragones
David G. Aragones
AHAndrés Hidalgo
Andrés Hidalgo

3 December 2025 in Nature
Verified
Journal Article
Open access
PDF file
DCDaniela Cerezo-Wallis
Daniela Cerezo-Wallis
ARAndrea Rubio-Ponce
Andrea Rubio-Ponce
MRMathis Richter
Mathis Richter
EPEmanuele Pitino
Emanuele Pitino
IKImmanuel Kwok
Immanuel Kwok
IBIván Ballesteros
Iván Ballesteros
Neutrophils exhibit remarkable phenotypic and functional diversity across tissues and diseases1,2, yet the lack of understanding of how this immune compartment is globally organized challenges translation to the clinic. Here we performed single-cell transcriptional profiling of neutrophils spanning 47 anatomical, physiological and pathological scenarios to generate an integrated map of the global neutrophil compartment in mice, which we refer to as NeuMap. NeuMap integrates and expands existing models3,4 to generate fundamental new insights; it reveals that neutrophils organize in a finite number of functional hubs that distribute sequentially during maturation to then branch out into interferon-responsive and immunosuppressive states, as well as a functionally silent state that dominates in the healthy circulation. Computational modelling and timestamp analyses identify prototypical trajectories that connect these hubs, and reveal that the dynamics and preferred paths vary during health, inflammation and cancer. We show that TGFβ, IFNβ and GM-CSF push neutrophils along the different trajectories, and projection of chromatin accessibility sites onto NeuMap reveals that the transcription factor JUNB controls angiogenic and immunosuppressive states and promotes tissue revascularization. The architecture of NeuMap appears to be conserved across sex, environmental and genetic backgrounds, as well as in humans. Finally, we show that NeuMap enables inference of the pathophysiological state of the host by profiling blood neutrophils. Our study delineates the global architecture of the neutrophil compartment and establishes a framework for exploration and exploitation of neutrophil biology.

16 January 2026 in Circulation Research
Verified
Journal Article
Open access
SVSandra Vázquez-Reyes
Sandra Vázquez-Reyes
AGAlicia García-Culebras
Alicia García-Culebras
GDGaohong Di
Gaohong Di
FCFrancisco J. De Castro-Millán
Francisco J. De Castro-Millán
BBBlanca Díaz Benito
Blanca Díaz Benito
MMMaría Ángeles Moro
María Ángeles Moro
BACKGROUND: Stroke remains a leading cause of mortality and disability, driven by complex, time-dependent mechanisms that aggravate ischemic injury. Collateral perfusion dictates infarct size, expansion rate, and penumbral preservation, yet its regulation is poorly understood. Beyond structural/genetic factors such as aging or cardiovascular risk, functional influences like circadian immune activity may also affect vascular patency. Neutrophils, key mediators of ischemic injury, exhibit circadian oscillations in phenotype and function that could modulate collateral flow and stroke outcome. METHODS: We combined permanent and transient middle cerebral artery occlusion models in mice with flow cytometry, single-cell RNA sequencing, confocal microscopy, and laser speckle imaging to investigate time-of-day–dependent neutrophil mechanisms in stroke. Pharmacological (chloramidine, DNase-I) and genetic (Pad4 [peptidyl arginine deiminase 4] −/ − , Bmal1 [brain and muscle ARNT (aryl hydrocarbon receptor nuclear translocator)-like 1] Neu , Cxcr4 [C-X-C chemokine receptor type 4] Neu ) interventions were used to define how time-of-day regulation shapes neutrophil function, neutrophil extracellular traps (NETs) formation, and stroke severity. A cohort of 540 patients with ischemic stroke was analyzed for diurnal patterns of NET-related biomarkers and their association with collateral circulation and clinical outcomes. RESULTS: Infarct volume and neurological deficits exhibited clear circadian oscillations, with worse outcomes when stroke occurred during the murine inactive phase (Zeitgeber time 5) versus the active phase (Zeitgeber time 13). These fluctuations disappeared after neutrophil depletion or clock disruption. During the inactive phase, neutrophils displayed an activated, NET-prone phenotype, causing microvascular stalling and reduced collateral perfusion. Inhibiting NET formation pharmacologically or through Pad4 deletion restored perfusion and abolished time-of-day effects. In patients, neutrophil and NET-related biomarkers (MPO [myeloperoxidase], elastase, sCD40L [soluble CD40 ligand]) showed diurnal oscillations, peaking during the human inactive phase (evening/night), coinciding with reduced collateral flow and poorer outcomes. CONCLUSIONS: Time-of-day regulation of neutrophil function critically determines collateral perfusion and stroke severity. Neutrophil-driven NETosis during the inactive phase promotes microvascular obstruction and worsens outcomes. Targeting NET formation or timing therapy could enhance collateral efficacy and offer novel chronotherapeutic opportunities for stroke treatment.

12 December 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
AAAlejandra Aroca-Crevillén
Alejandra Aroca-Crevillén
SMSandra Martín-Salamanca
Sandra Martín-Salamanca
Lidiane S TorresLidiane S Torres
Lidiane S Torres
GCGeorgiana Crainiciuc
Georgiana Crainiciuc
JSJon Sicilia
Jon Sicilia
AHAndrés Hidalgo
Andrés Hidalgo
Inflammation-driven injury, a significant source of morbidity and mortality worldwide, is largely mediated by the cytotoxic activities of neutrophils, which extend the initial lesion and jeopardize organ function. Intriguingly, inflammatory injury naturally declines at specific times of day, suggesting that circadian mechanisms exist that mitigate the destructive activity of neutrophils and protect the host. Here, we show that the periods of diurnal protection coincide with peaks in plasma CXCL12, a chemokine that inhibits the neutrophil-intrinsic circadian clock by signaling through CXCR4. Genetic deletion of this clock, or a hyperactive form of CXCR4, prevented the diurnal spikes of injury, and treatment with a synthetic CXCR4 agonist conferred protection from myocardial and vascular injury. In tissues, this protection was mediated by repositioning neutrophils in the wound core, which spared neighboring host cells from apoptotic death. Thus, a circadian neutrophil checkpoint protects from exuberant inflammation and can be activated to protect the host.